News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
482,946 Results
Type
Article (8015)
Company Profile (139)
Press Release (474696)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166737)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52873)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238190)
Policy (17898)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (478)
Accelerated approval (21)
ADA (18)
Adcomms (1)
Allergies (94)
Alliances (33154)
ALS (102)
Alzheimer's disease (963)
Antibody-drug conjugate (ADC) (251)
Approvals (10326)
Artificial intelligence (306)
ASCO (159)
Autoimmune disease (194)
Automation (27)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
BIOSECURE Act (1)
Biosimilars (101)
Biotechnology (88)
Bladder cancer (132)
Brain cancer (27)
Breast cancer (497)
Cancer (3533)
Cardiovascular disease (212)
Career advice (245)
Career pathing (1)
CAR-T (166)
Celiac Disease (1)
Cell therapy (463)
Cervical cancer (34)
Clinical research (47698)
Collaboration (1195)
Compensation (1378)
Complete response letters (33)
COVID-19 (748)
CRISPR (62)
C-suite (696)
Cystic fibrosis (84)
Data (5464)
Denatured (4)
Depression (101)
Dermatology (58)
Diabetes (332)
Diagnostics (4137)
Digital health (36)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (144)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (156)
Earnings (72989)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87402)
Executive appointments (675)
FDA (12262)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (16)
Frontotemporal dementia (23)
Funding (886)
Gene editing (123)
Generative AI (9)
Gene therapy (307)
GLP-1 (283)
Government (938)
Grass and pollen (2)
Guidances (278)
Healthcare (9305)
Hematology (94)
HIV (49)
Huntington's disease (22)
IgA nephropathy (60)
Immunology and inflammation (95)
Immuno-oncology (53)
Indications (148)
Infectious disease (933)
Inflammatory bowel disease (125)
Inflation Reduction Act (4)
Influenza (83)
Intellectual property (245)
Interviews (41)
IPO (12377)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (14)
Layoffs (59)
Legal (5195)
Liver cancer (43)
Longevity (15)
Lung cancer (485)
Lymphoma (240)
Machine learning (27)
Management (3)
Manufacturing (506)
Marketing (6)
MASH (115)
Medical device (8627)
Medtech (8743)
Mergers & acquisitions (14345)
Metabolic disorders (685)
mRNA (50)
Multiple sclerosis (100)
NASH (4)
Neurodegenerative disease (209)
Neuropsychiatric disorders (38)
Neuroscience (1773)
NextGen: Class of 2026 (3150)
Non-profit (840)
Obesity (219)
Opinion (10)
Ovarian cancer (154)
Pain (167)
Pancreatic cancer (189)
Parkinson's disease (195)
Partnered (11)
Patents (454)
Patient recruitment (469)
Peanut (31)
People (41100)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15420)
Phase 2 (21298)
Phase 3 (14342)
Pipeline (6579)
Policy (18)
Postmarket research (1570)
Preclinical (6524)
Press Release (34)
Prostate cancer (185)
Psychedelics (7)
Radiopharmaceuticals (187)
Rare diseases (550)
Real estate (3018)
Recruiting (6)
Regulatory (14649)
Reports (16)
Research institute (578)
Resumes & cover letters (45)
Rett syndrome (39)
RNA editing (5)
RSV (47)
Schizophrenia (97)
Series A (147)
Series B (116)
Service/supplier (4)
Sickle cell disease (61)
Spinal muscular atrophy (86)
Sponsored (5)
Startups (2018)
Stomach cancer (3)
Supply chain (47)
Vaccines (308)
Venture capital (17)
Weight loss (69)
Women's health (73)
Date
Today (54)
Last 7 days (278)
Last 30 days (1123)
Last 365 days (19085)
2026 (10490)
2025 (19251)
2024 (22985)
2023 (26541)
2022 (34587)
2021 (37167)
2020 (33479)
2019 (23256)
2018 (17493)
2017 (18765)
2016 (17917)
2015 (24263)
2014 (21679)
2013 (18138)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (226)
Alabama (68)
Alaska (2)
Arizona (289)
Arkansas (11)
Asia (17822)
Australia (2088)
California (11445)
Canada (3035)
China (496)
Colorado (462)
Connecticut (387)
Delaware (200)
Europe (24555)
Florida (1707)
Georgia (362)
Hawaii (2)
Idaho (46)
Illinois (671)
India (40)
Indiana (307)
Iowa (13)
Japan (383)
Kansas (98)
Kentucky (30)
Louisiana (24)
Maine (25)
Maryland (1144)
Massachusetts (7547)
Michigan (299)
Minnesota (533)
Mississippi (4)
Missouri (76)
Montana (20)
Nebraska (11)
Nevada (112)
New Hampshire (60)
New Jersey (2523)
New Mexico (11)
New York (2721)
North Carolina (1221)
North Dakota (4)
Northern California (5689)
Ohio (263)
Oklahoma (14)
Oregon (14)
Pennsylvania (2183)
Puerto Rico (20)
Rhode Island (29)
South America (405)
South Carolina (75)
South Dakota (1)
Southern California (4747)
Tennessee (111)
Texas (1844)
United States (37255)
Utah (341)
Vermont (1)
Virginia (144)
Washington D.C. (38)
Washington State (888)
West Virginia (1)
Wisconsin (71)
482,946 Results for "auransa inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Auransa and POLARISqb enter research collaboration finding treatments for neglected women’s diseases
Auransa, Inc., an artificial intelligence (AI) company developing precision medicines in areas of unmet medical needs, and Polaris Quantum Biotech (POLARISqb), a quantum drug design company, announced a research collaboration addressing therapeutics for neglected diseases disproportionately affecting women.
June 4, 2021
·
3 min read
Press Releases
Encision Inc. Announces Start of Stock Trading
July 14, 2026
·
1 min read
Press Releases
La Jolla Labs Inc., Unravel Biosciences Inc., and Ulm University Announce Strategic Collaboration to Advance AI-Driven Therapeutics for ALS
July 16, 2026
·
1 min read
Press Releases
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
July 2, 2026
·
12 min read
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Update
August 19, 2025
·
2 min read
Press Releases
Cellution Biologics Inc. Signs Definitive Agreement to Acquire SimpliDerm® Human Hydrated Acellular Dermal Matrix Business from Elutia Inc., Expanding its Allograft Portfolio
July 16, 2026
·
3 min read
Press Releases
Zymeworks to Acquire Theravance Biopharma, Inc.
June 29, 2026
·
17 min read
Drug Development
Auransa Presents New Preclinical Data on AU-409, a Novel, AI-Derived Drug Candidate for the Treatment of Hepatocellular Carcinoma
Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of significant unmet medical need, today announced that new data on AU-409, the company’s novel lead drug candidate being developed for the treatment of hepatocellular carcinoma (HCC), were presented at the 13th Annual Conference of the International Liver Cancer Association (ILCA) in Chicago.
September 24, 2019
·
4 min read
Press Releases
Definium Therapeutics, Inc. Announces Proposed Public Offering
June 23, 2026
·
6 min read
Press Releases
Belmont Medical Completes Acquisition of Arcos, Inc.
June 17, 2026
·
4 min read
1 of 48,295
Next
